SPRO vs UPS · P/E 9.6, rev $48.0M vs P/E 15, rev $88.66B
Spero Therapeutics Inc (SPRO) versus United Parcel Service Inc (UPS) — a side-by-side from cached financials, not a winner call.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
United Parcel Service Inc (UPS) is a integrated freight & logistics company listed on US.
Latest reported SPRO revenue for 2024-12-31 was $48.0M. Net income was -$68.6M. Revenue was down 53.8% from 2023-12-31 to 2024-12-31. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Latest reported UPS revenue for 2025-12-31 was $88.66B. Net income was $5.57B. Revenue was down 2.6% from 2024-12-31 to 2025-12-31. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
SPRO currently screens at market cap $149.5M and trailing P/E 9.6. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
Not investment advice. Open the SPRO and UPS stock pages for the full models.
Not investment advice.